Abstract:A growing number of studies have found that individuals with chronic, low-grade inflammation report greater cognitive impairment and worse performance on a wide range of tests measuring important cognitive abilities, such as episodic memory, processing speed, and executive function. There also is strong evidence linking inflammation with neurodegenerative processes, evident in the 45% increased risk for dementia linked to chronic, low-grade inflammation. Despite general agreement that inflammation is related to cognition, many unanswered questions remain. The goal of this symposium is to advance our understanding on the causal relationship between inflammation and cognition by exploring some recent findings in this area, progressively moving from cross- sectional and longitudinal observational studies to ones that permit stronger causal inference through the use of Mendelian randomization analyses and randomized placebo-controlled design. The first talk investigates the interplay of diet quality, cognition and inflammation in healthy young adults. Although both aspects of diet quality and a circulating inflammatory biomarker – tumor necrosis factor-α – were both associated with worse performance on a composite measure of higher-order cognitive abilities (Fluid Composite T- score assessing inhibitory control, cognitive flexibility, working memory, episodic memory, and processing speed on the NIH Toolbox Cognition Battery), diet and circulating inflammatory biomarkers were unrelated. These data suggest, at least in young adults, that poorer diet and tumor necrosis factor-α exert an impact on cognitive function via different pathways. The second talk explores the relationship between inflammation and executive functioning in a longitudinal study of adolescent at high-risk for depression (over-sampled for exposure to early life adversity). These data show that higher levels of interleukin-10 were linked with worse executive functioning in the emotion regulation domain, which in turn increased risk for subsequent depression over the following 12-months. These data suggest that, during adolescence, immune-related difficulties in executive function are primarily observable when required to regulate emotion and that they increase risk for depression. The third talk examines the causal relationship between inflammation and cognitive function in a population-based cohort (Avon Longitudinal Study of Parents and Children) using both associational and Mendelian randomization analyses. Associations between inflammatory markers and cognitive domains (working memory, response inhibition, emotion recognition) did not survive adjustment for potential confounders and there was limited evidence that a 1-unit increase in genetically-proxied inflammatory markers impacted standardized cognitive function in one- or two-sample Mendelian randomization analyses. These data caution against a simple causal relationship between higher levels of C-reactive protein, interleukin-6, and Glycoprotein Acetyls with working memory, response inhibition, and emotion recognition and highlight the importance of a clear theoretical framework on how immune dysfunction impacts cognition. Finally, the fourth talk will demonstrate that lower concentrations of interleukin-6 in lipopolysaccharide-stimulated peripheral blood mononuclear cells were associated with greater impairment in higher-order cognitive functions (e.g., word-finding, memory) in depressed individuals exhibiting a pro-inflammatory phenotype. Importantly, when these individuals were randomized to receive 4/grams of omega-3 daily over 12 weeks in a randomized placebo- controlled clinical trial, it was motivational symptoms related to cognition (e.g., energy, alertness), but not higher- order cognitive function, that improved. Lower concentrations of IL-6 in lipopolysaccharide-stimulated peripheral blood mononuclear cells – indicative of decreased immune cell competence and suggestive of longer-lasting immune dysfunction – may be associated with higher-order cognitive difficulties that do not improve in the short- term following anti-inflammatory treatment, as opposed to motivational symptoms which were shown to improve over a 12 week period. This symposium provides strong indication that immune dysfunction may indeed be related to cognitive dysfunction and highlights some of the unanswered questions future research will need to explore to draw firmer conclusions. A better understanding is needed of which domains of cognitive function are impacted by immune dysfunction, under which conditions they are affected, and by which immune-based mechanisms. Dr. Andrew H. Miller, as chair, will discuss the importance of theory development that identifies modifiable predictors of immune dysfunction, peripheral immune dysfunction related to cognition, the specific neural pathways affected by peripheral immune dysfunction, the behavioral correlates of dysfunctional neural pathways, as well as the conditions under which dysfunction emerges (e.g., stress, extended exposure to immune activation). Data presented here identify directions for future work, such as: (i) disentangling potential acute effects of inflammation on frontostriatal circuitry that underpin deficits in energy, alertness, motivation from potentially more longer terms impacts on executive function and/or episodic memory; (ii) better characterizing the conditions under which cognitive difficulties are detectable (e.g., conditions of stress); (iii) the importance of conceptualizing immune dysfunction beyond elevations in circulating inflammatory cytokines and utilizing enumerative and functional assays of immune cell populations. The proposed symposium is based on some of the latest research being produced by a diverse (in terms of sex, geography, and career stage) group of researchers.

Mechanisms of inflammation in psychosis

Understanding the Causal Relationship Between Inflammation and Cognition: Data From Randomized Controlled Trials, Mendelian Randomization, and Observational Studies

Immuno-NeuroPsychiatry on the Path to Clinical Application

Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies

- Association of Neuropsychiatric Symptoms with Inflammation: Review Findings from the Workshop on Brain Immune Interactions

Inflammation in psychosis: A potential role for Toll-like receptors

Early life adversities in the etiology of mental illness: the role of immune mechanisms

- Immune biomarkers in psychiatric illness: Findings from the biomarker subgroup of the NSAS Brain-Immune Interactions Workshop

A study on the complex interplay between inflammation and severe mental disorders (SMInflam)

Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort

Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis

Inflammation Proteomic Profiling of Psychosis in Young Adults: findings from the ALSPAC birth cohort

Temporal Changes in Brain Morphology Related to Inflammation and Schizophrenia: an Omnigenic Mendelian Randomization Study.

A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup

Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders

Measuring the impact of the environment in developing mental health disorders: highlighting innovation in methodology

Brain-immune crosstalk in the treatment of major depressive disorder

Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology

Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders

Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder